HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alveolar soft part sarcoma in childhood: is Sunitinib-Sutent® treatment an effective approach?

AuthorsMarjorie Hilbert, Pierre Mary, Michelle Larroquet, Marie-Odile Serinet, Sylvie Helfre, Herve Brisse, Aurore Coulomb, Daniel Orbach
JournalPediatric blood & cancer (Pediatr Blood Cancer) Vol. 58 Issue 3 Pg. 475-6 (Mar 2012) ISSN: 1545-5017 [Electronic] United States
PMID22234817 (Publication Type: Case Reports, Letter)
Chemical References
  • Angiogenesis Inhibitors
  • Indoles
  • Pyrroles
  • Receptor Protein-Tyrosine Kinases
  • Sunitinib
Topics
  • Adolescent
  • Angiogenesis Inhibitors (therapeutic use)
  • Child
  • Combined Modality Therapy
  • Female
  • Humans
  • Indoles (therapeutic use)
  • Lung Neoplasms (drug therapy, secondary, surgery)
  • Pyrroles (therapeutic use)
  • Receptor Protein-Tyrosine Kinases (antagonists & inhibitors)
  • Sarcoma, Alveolar Soft Part (drug therapy, secondary, surgery)
  • Sunitinib

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: